Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections by Mensi, C et al.
ORIGINAL ARTICLE
Incidence of mesothelioma in Lombardy, Italy:
exposure to asbestos, time patterns and future
projections
Carolina Mensi,1 Sara De Matteis,2 Barbara Dallari,1 Luciano Riboldi,1
Pier Alberto Bertazzi,1 Dario Consonni1
▸ Additional material is
published online only. To view
please visit the journal online
(http://dx.doi.org/10.1136/
oemed-2016-103652).
1Department of Preventive
Medicine, Fondazione IRCCS
Ca’ Granda Ospedale
Maggiore Policlinico, Milan,
Italy
2National Heart and Lung
Institute, Respiratory
Epidemiology, Occupational
Medicine and Public Health,
Imperial College London,
London, UK
Correspondence to
Dr Dario Consonni,
Department of Preventive
Medicine, Fondazione IRCCS
Ca’ Granda Ospedale
Maggiore Policlinico, Via San
Barnaba, 8, Milano 20122,
Italy; dario.consonni@unimi.it
Received 17 February 2016
Revised 23 May 2016
Accepted 31 May 2016
To cite: Mensi C,
De Matteis S, Dallari B,
et al. Occup Environ Med
Published Online First:
[please include Day Month
Year] doi:10.1136/oemed-
2016-103652
ABSTRACT
Objectives In Italy, asbestos has been extensively used
from 1945 to 1992. We evaluated the impact of
exposure to asbestos on occurrence of malignant
mesothelioma (MM) in the Lombardy Region, Northwest
Italy, the most populated and industrialised Italian
region.
Methods From the Lombardy Mesothelioma Registry,
we selected all incident cases of MM diagnosed
between 2000 and 2012. We described sources of
exposure to asbestos and examined time trends of MM
rates. Using Poisson age-cohort models, we derived
projections of burden of MM in the Lombardy
population for the period 2013–2029.
Results In 2000–2012, we recorded 4442 cases of
MM (2850 men, 1592 women). Occupational exposure
to asbestos was more frequent in men (73.6%) than in
women (38.2%). Non-occupational exposure was found
for 13.6% of women and 3.6% of men. The average
number of cases of MM per year was still increasing
(+3.6% in men, +3.3% in women). Incidence rates
were still increasing in individuals aged 65+ years and
declining in younger people. A maximum of 417 cases
of MM (267 men, 150 women) are expected in 2019.
We forecast there will be 6832 more cases (4397 in
men, 2435 in women) in the period 2013–2029, for a
total of 11 274 cases of MM (7247 in men, 4027 in
women) in 30 years.
Conclusions This study documented a high burden of
MM in both genders in the Lombardy Region, reﬂecting
extensive occupational (mainly in men) and non-
occupational (mainly in women) exposure to asbestos in
the past. Incidence rates are still increasing; a downturn
in occurrence of MM is expected to occur after 2019.
INTRODUCTION
Asbestos is a known carcinogen to humans that
causes malignant mesothelioma (MM), lung, laryn-
geal and ovarian cancer, while evidence regarding
its association with other cancer sites (pharynx,
stomach, colon and rectum) is considered limited.1
All forms of asbestos are recognised to possess car-
cinogenic properties, although with different
potencies (with regard to MM, amphiboles are
more potent than chrysotile). In addition, asbestos
may cause non-neoplastic diseases, including asbes-
tosis and pleural effusions and plaques. It has been
estimated that, worldwide, 107 000 people die
from MM, lung cancer, or asbestosis every year.2
Most MM are caused by asbestos (or other asbes-
tiform ﬁbres, like erionite and ﬂuoro-edenite).3
Prognosis is very poor and has not improved in the
last decades. Hence, MM, and/or incidence and
mortality of pleural cancer have been largely used
to monitor the health impact of exposure to asbes-
tos worldwide. Currently, the largest burden of
incidence and mortality in MM is in countries that
began using asbestos a long time ago (in Western
Europe, North America and Oceania). Most of
them have banned the extraction, sale and use of
asbestos. However, in most countries in Asia,
Eastern Europe and South America, chrysotile is
still in use and its health implications are over-
looked due to the fact that MM is a rare cancer
and its burden is currently apparently low for dif-
ferent reasons, including under-reporting and mis-
coding and, most importantly, the fact that in those
countries the use of asbestos started later.2 4
Hence, given the long latency between exposure to
asbestos and occurrence of MM, the burden
What this paper adds
▸ Depending on the pattern of use of asbestos in
the past, occurrence of mesothelioma is
decreasing in some countries but is still
increasing in others.
▸ Italy has been using large quantities of
asbestos till the 1992 ban, and is currently
among those countries with the highest
worldwide mortality of mesothelioma.
▸ Using mesothelioma registry data, we
evaluated the incidence of mesothelioma in the
most populated (currently, 10 million people)
and industrialised Italian region, and made
future projections as of 2029.
▸ In 2000–2012 we recorded more than 4400
cases, and have forecast that there will be a
total of about 11 000 cases (7000 in men and
4000 in women) in a 30-year period
(2000–2029).
▸ Documenting occurrence of mesothelioma may
help to increase awareness of dangers of
exposure to asbestos in countries that still use
it, but where its health effects are still
overlooked.
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of MM and other cancers in those countries is expected to
increase in the coming years. For these reasons, many research-
ers and organisations have called for a global ban on asbestos.5
Several countries have established MM registries to monitor
incidence of MM over time, identify sources of exposure to
asbestos, provide medicolegal assistance to patients and their
familiars, evaluate survival and forecast future trends of inci-
dence of MM.6–9 Italy has been using large quantities of chryso-
tile and amphiboles from 1945 to the 1992 ban, and is
currently among the countries with the highest frequency of
MM worldwide.4 In Italy, a national MM registry (Registro
Nazionale Mesoteliomi, ReNaM) has been implemented and
organised as a network of regional registries.7
Our aim was to describe the results of the MM registry of the
Lombardy Region (Registro Mesoteliomi Lombardia, RML),
Northwest Italy, the most populated (currently 10 million inha-
bitants, one-sixth of the Italian population) and industrialised of
the 20 Italian regions. For years 2000–2012, we assessed
sources of exposure to asbestos, examined MM time patterns,
and for 2013–2029 we derived projections of burden of MM
on the Lombardy population using age-cohort models.
METHODS
Ascertainment of mesothelioma cases
The RML is a population-based registry. Since 2000 it has been
collecting all cases of MM reported among Lombardy residents
at the time of diagnosis.10 The primary source is the reporting
of MM (compulsory by law: 277/1991 and 81/2008) from
every hospital. Completeness of ascertainment is periodically
veriﬁed using several sources, notably pathology, hospital admis-
sion and mortality databases. Final diagnosis is established on a
case-by-case basis considering all available clinical information,
classifying cases as ‘certain MM’ (histological diagnosis of MM,
possibly with immunohistochemical conﬁrmation and imaging);
‘probable MM’ (usually, cytology suggesting MM plus imaging);
‘possible MM’ (positive imaging), or ‘non-MM’. Morphology is
deﬁned and coded according to WHO histological classiﬁcation
and the International Classiﬁcation of Diseases for Oncology
(ICD-O), Third Edition.
Assessment of exposure to asbestos
Patients of MM (or their next-of-kin) are interviewed (mostly
face-to-face) by trained personnel using a standardised question-
naire to collect information on lifetime occupational history
(industry, occupation, work environment characteristics). In add-
ition, the patient is asked to provide information on each
cohabitant, including longest occupation, years lived with them,
and brushing or washing of dirty work clothes at home.
Home-related activities involving potential exposure to asbestos
are also investigated, including ironing on asbestos-coated
ironing-boards, small repair works, thermal insulation, use of
asbestos gloves, and use of any asbestos-containing objects.
Finally, the questionnaire also contains a section on lifetime resi-
dential history, including questions on house type, presence of
asbestos-cement tiles or water tanks, and presence of industries
in the vicinity (eg, asbestos-cement, petrochemical, railroad, or
shipbuilding industries). On the basis of this information, the
lifetime asbestos exposure is classiﬁed as ‘occupational’ (certain,
probable, or possible), ‘para-occupational’ (exposure through
the cohabitants), ‘home-related’, or ‘environmental’.
Individuals may have been exposed to asbestos from more than
one source. Patients ever exposed to asbestos at the workplace
(where levels of airborne asbestos were usually of orders of mag-
nitudes higher than in other settings), are classiﬁed as
occupationally exposed irrespective of other sources of exposure
(para-occupational, home-related, or environmental). For patients
never occupationally exposed to asbestos, we usually follow this
hierarchy of exposure: para-occupational>home-related>
environmental. However, the ﬁnal decision is taken on a
case-by-case basis, considering also information on time since ﬁrst
exposure and length of exposure to each source.
Statistical analysis
We selected from the RML database all cases of MM diagnosed
between 1 January 2000 and 31 December 2012, the period in
which activities of case ascertainment, evaluation and interview
have been completed. For each year from 2000 to 2012, we cal-
culated crude and standardised rates for men and women using
the Italian 2001, the European and the World (Segi’s) standard
populations. We ﬁtted crude and age-adjusted Poisson regression
models to calculate MM case and rate change (%) per year. We
plotted incidence rates by age at diagnosis, period of diagnosis
and birth cohort, for men and women separately, after combin-
ing the extreme classes of age (ages 20–34 years) and birth
cohorts (cohorts 1900–1909 and 1970–1989) because of small
numbers. We evaluated possible differences in time patterns
between men and women by including gender-age and/or
gender-cohort interaction terms in the Poisson models. Model
comparisons were performed using likelihood ratio (LR) tests
between nested models. In addition, we ﬁtted separate Poisson
models using cases classiﬁed as occupationally and non-
occupationally exposed to asbestos, respectively (individuals
without information were excluded). Figures calculated in this
way are not interpretable in absolute terms (rates) because popu-
lation data (denominators) are not stratiﬁed by exposure to
asbestos, but they are, nonetheless, useful for relative (rate
ratios) time pattern comparisons.
To make projections, we ﬁtted categorical Poisson age-cohort
models using 5-year categories for age at diagnosis (reference:
70–74 years) and birth cohort (reference: cohort 1920–1924).11
The gender-speciﬁc age and cohort regression coefﬁcients were
then applied to population data to calculate projections of the
numbers of cases of MM and their 90% CIs in the years 2013–
2029. Actual (2000–2015) and estimated (2016–2029, inter-
mediate scenario) population data, by year, gender and age were
downloaded from the National Institute of Statistics website
(http://demo.istat.it/index_e.html). We also made projections
stratiﬁed by exposure to asbestos. Data management and statis-
tical analyses were performed with Stata V.13.
RESULTS
Characteristics of mesothelioma patients and exposure to
asbestos
In 2000–2012, we identiﬁed 4442 persons with MM, 2850
men (64.2%) and 1592 women (35.8%), with a male/female
ratio of 1.79 (table 1). Median age at diagnosis was 70.4 years
in men and 73.8 years in women. Pleura was the site of origin
of MM in more than 90% of cases. The number of pleural MM
was much higher in men than in women, while the number of
peritoneal MM was similar. Diagnosis was evaluated as certain
in more than three-quarters of cases. Morphology was obtained
in more than 80% of patients. The most represented morph-
ology was the epithelioid. Pleural plaques were detected in
13.8% of men and 8.0% of women. Interviews were obtained
for more than 90% of affected persons, either from the patients
themselves or from one of their relatives.
Occupational exposure was documented in 73.6% of men
and 38.2% in women. Para-occupational, home-related and
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environmental asbestos exposures were more frequent in
women (13.6% in total) than in men (3.6%). For 493 men
(17.3%) and 624 women (39.2%) no evidence of asbestos
exposure was found at interview. For 156 men (5.5%) and 144
women (9.0%) information on exposure to asbestos was lacking
(no interview) or insufﬁcient (non-informative interview).
Median length of occupational exposure was 28.0 years in men
and 13.0 years in women, while median time since ﬁrst occupa-
tional exposure was 49.5 years (men) and 56.2 years (women).
In men, about one-third of cases had been exposed to asbestos
in metalmechanic and metallurgy industries, one-third in build-
ing construction, and the remaining in various sectors. The
majority of women (65.5%) had been exposed to asbestos in
the non-asbestos textile (cotton, wool and silk manufacture) and
clothing production sectors. We compared gender-speciﬁc case
distributions across the same industries reported in table 1
between those classiﬁed as occupationally exposed to asbestos
(2099 men and 608 women), and for whom we were not able
to identify any (occupational, para-occupational, home-related,
or environmental) exposure to asbestos (493 men and 624
women) (see online supplementary table S1, upper half). Except
for building construction (men), textile (women) and asbestos-
cement and railroad production/maintenance industries, case
distributions were similar between asbestos-exposed and non-
exposed persons. However, there remains a substantial propor-
tion of individuals who have been ever employed in other indus-
trial sectors (eg, trade, agriculture and livestock, education,
bank, insurance and mail) for which we did not ﬁnd any evi-
dence of exposure to asbestos at interview (see online supple-
mentary table S1, lower half).
Exposure to asbestos (any) was similar across the MM site. In
those interviewed, 2083 (81.0%) men with pleural MM, 102
(81.0%) with peritoneal MM, 4 (80.0%) with pericardial MM,
and 12 (75.0%) with MM of tunica vaginalis testis had ever
been exposed to asbestos (p value=0.99). In women, exposure
to asbestos was documented for 767 (56.4%) with pleural MM,
55 (49.1%) with peritoneal MM, and 2 (40.0%) with pericar-
dial MM (p value=0.40). When restricting analyses to certain
MM diagnoses and individuals directly interviewed (patients),
the numbers (proportions) of men with past exposure to asbes-
tos were 1235 (84.5%) for pleura, 50 (82.0%) for peritoneum,
1 (50%) for pericardium and 8 (100%) for tunica vaginalis
testis (p value=0.31). The corresponding ﬁgures in women
were 348 (58.1%) for pleura and 24 (58.5%) for peritoneum
(p value=0.90).
Time patterns, 2000–2012, and future projections, 2013–2029
The number of cases of MM increased from 277 in 2000 to
403 in 2012 (table 2). On average, over the 13-year period,
there was a 3.6% per year increase of cases of MM in men and
3.3% in women. Crude rates (per 100 000 person-years)
went from 4.0 to 5.8 in men (average crude and age-adjusted
increase/year 2.6% and 1.3%), and from 2.2 to 2.6 in women
(average crude and age-adjusted increase/year 2.5% and 1.6%).
Pleural MM increased from 262 cases in 2000 to 389 cases in
2012. Peritoneal MM went from 14 cases in 2000 to 29 in
2011, with a drop in 2012 (13 cases). Trends in pericardial and
cases of tunica vaginalis testis are difﬁcult to recognise, because
the number of cases was very small (from 1 to 4 cases per year).
Age-speciﬁc MM rates were higher and increased over the
study period in men over 65 years in men and women, while a
decrease was observed for younger persons (see online supple-
mentary table S2). In particular, from age-adjusted Poisson
regression models, the annual rate changes in individuals aged
Table 1 Characteristics of persons with malignant mesothelioma
by gender, Lombardy Region Mesothelioma Registry, 2000–2012
Men Women
N Per cent N Per cent
Total 2850 100 1592 100
Age at diagnosis (years)
20–49 113 4.0 49 3.1
50–54 118 4.1 45 2.8
55–59 212 7.4 91 5.7
60–64 396 13.9 150 9.4
65–69 523 18.4 238 15.0
70–74 608 21.3 295 18.5
75–79 461 16.2 311 19.5
80–84 257 9.0 247 15.5
85+ 162 5.7 166 10.4
Site
Pleura 2693 94.5 1462 91.8
Peritoneum 134 4.7 125 7.9
Pericardium 6 0.2 5 0.3
Tunica vaginalis testis 17 0.6 – –
Diagnosis
Certain 2340 82.1 1203 75.6
Probable 245 8.6 157 9.9
Possible 265 9.3 232 14.6
Morphology (ICD-O code)
MM not otherwise specified (90503) 169 5.9 107 6.7
Fibrous/sarcomatoid/desmoplastic MM
(90513)
241 8.5 76 4.8
Epithelioid MM (90523) 1707 59.9 967 60.7
Biphasic MM (90533) 391 13.7 152 9.6
Unknown 342 12.0 290 18.2
Presence of pleural plaques 394 13.8 127 8.0
Interview
Patient 1658 58.2 706 44.4
Relative 1061 37.2 771 48.4
Not performed 131 4.6 115 7.2
Asbestos exposure source
Occupational 2099 73.6 608 38.2
Para-occupational 16 0.6 63 4.0
Home-related 24 0.8 75 4.7
Environmental 62 2.2 78 4.9
Unknown* 493 17.3 624 39.2
No information/not classified† 156 5.5 144 9.0
Occupational asbestos exposure: industry‡ 2099 100 608 100
Metalmechanic and metallurgy 731 34.8 51 8.4
Building construction 705 33.6 0 0.0
Textile and clothing production 188 9.0 398 65.5
Chemical 122 5.8 18 3.0
Motor vehicle production 136 6.5 7 1.1
Food and beverage 98 4.7 21 3.5
Rubber 71 3.4 23 3.8
Military 87 4.1 0 0.0
Asbestos-cement 65 3.1 12 2.0
Health and social services 39 1.9 38 6.3
Transport 76 3.6 0 0.0
Railroad production and maintenance 51 2.4 3 0.5
Energy production 51 2.4 0 0.0
*Individuals without any identified asbestos exposure.
†Not interviewed or with insufficient information at interview.
‡Only industries with at least 50 cases are listed; a person may have been exposed to
asbestos in more than one industrial sector in his/her occupational history.
ICD-O, International Classification of Diseases for Oncology, Third Edition; MM,
malignant mesothelioma.
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65+ years were +3.4% in men and +3.5% in women, while
for those aged <65 years they were −3.0% in men and −4.3%
in women. Incidence rates ranged from 22.7 to 28.1 per
100 000 person-years between 70 years and 94 years of age at
diagnosis in men (see online supplementary table S3, rightmost
column). In women, rates between 10.3 and 12.2 per 100 000
person-years were recorded for women aged 75–89 years (see
online supplementary table S4, rightmost column). In men, the
highest burden of MM, 2278 cases (79.9%), was among those
born between 1925 and 1949 (men) (see online supplementary
table S3, penultimate row). The highest rates were found for
men born between 1905 and 1949 (ﬁgure 1 and online supple-
mentary table S3, last row). In women, 1080 cases of MM
(67.8%) occurred in those born between 1925 and 1944 (see
online supplementary table S4, penultimate row). The highest
rates were found for women born between 1900 and 1944
Table 2 Number of cases, person-years, and crude and age-standardised rates (per 100 000 person-years, age 0–99 years) of malignant
mesothelioma (MM) by gender and year of diagnosis, Lombardy Region Mesothelioma Registry, 2000–2012
Year
Men Women
Cases Person-years
Rate
Cases Person-years
Rate
Crude Italy* Europe† World‡ Crude Italy* Europe‡ World‡
2000–2012 2850 59 685 638 4.8 5.3 3.5 2.4 1592 62 922 196 2.5 2.2 1.4 0.9
2000 174 4 340 561 4.0 4.9 3.3 2.2 103 4 630 593 2.2 2.0 1.5 1.0
2001 182 4 358 338 4.2 4.8 3.4 2.3 99 4 645 746 2.1 2.0 1.4 1.0
2002 193 4 374 405 4.4 5.1 3.4 2.3 116 4 659 197 2.5 2.2 1.5 1.0
2003 209 4 417 259 4.7 5.5 3.7 2.5 104 4 691 386 2.2 2.0 1.3 0.9
2004 193 4 497 954 4.3 4.9 3.3 2.2 103 4 748 842 2.2 1.8 1.2 0.8
2005 219 4 579 992 4.8 5.3 3.7 2.5 120 4 813 100 2.5 2.1 1.4 0.9
2006 196 4 624 741 4.2 4.8 3.2 2.2 127 4 850 461 2.6 2.2 1.5 1.0
2007 227 4 660 352 4.9 5.4 3.6 2.4 130 4 885 089 2.7 2.3 1.5 1.0
2008 221 4 711 487 4.7 5.1 3.3 2.2 134 4 930 919 2.7 2.3 1.5 0.9
2009 252 4 762 370 5.3 5.6 3.8 2.5 107 4 980 306 2.1 1.8 1.1 0.7
2010 254 4 802 363 5.3 5.7 3.7 2.4 155 5 023 778 3.1 2.6 1.7 1.2
2011 255 4 844 524 5.3 5.6 3.5 2.3 166 5 073 190 3.3 2.6 1.6 1.0
2012 275 4 711 292 5.8 6.1 3.8 2.5 128 4 989 589 2.6 1.9 1.2 0.8
Change/year +3.6 +2.6 +1.3§ +3.3 +2.5 +1.6§
*Rates standardised on the Italian population, 2001.
†Rates standardised on the European population.
‡Rates standardised on the world (Segi’s) population.
§From age-adjusted Poisson regression models.
Figure 1 Incidence rates (per 100 000 person-years) of malignant mesothelioma (20–99 years of age) (no cases were recorded in persons
<20 years of age. Owing to small number of cases, ages 20–24, 25–29, and 30–34 and birth cohorts 1900–1904, 1905–1909, 1970–1974,
1975–1979, 1980–1984, and 1985–1989 were combined) by birth cohort for different categories of age at diagnosis, Lombardy Region
Mesothelioma Registry, 2000–2012.
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(ﬁgure 1 and see online supplementary table S4, last row).
Incidence rates by birth cohort show similar patterns of increase
by age class, except for some recent cohorts with few cases
(1965–1969 in men and 1955–1959 in women) (ﬁgure 2 and see
online supplementary tables S3 and S4). Accordingly, we did not
ﬁnd statistical evidence of different patterns between men and
women (LR tests for interaction terms yielded the following
results: gender-age plus gender-cohort interactions: p value=0.47;
gender-age interaction: p value=0.31, gender-cohort interaction:
p value=0.40). When we stratiﬁed rates by occupational exposure
to asbestos (see online supplementary ﬁgures S1–S4), relative
patterns were roughly similar across gender, with p values for
interactions ranging from 0.21 to 0.89.
Poisson age-cohort models showed a good ﬁt (p values=0.39/
0.63 for men/women). Fitted number of cases of MM were
quite close to the observed (results not shown). These models
conﬁrmed the higher rates for those born 1925–1949 (men)
and 1925–1944 (women). Application of gender-speciﬁc age
and birth cohort regression coefﬁcients to population data
yielded the projection curves for the annual number of cases of
MM shown in ﬁgure 3. The peak in cases of MM is expected to
occur in 2019 for both genders (267 in men and 150 in
women). The projected number of cases in 2012–2030 is 6832
(90% CI 5333 to 9184), 4397 (90% CI 3505 to 5860) in men
and 2435 (90% CI 1828 to 3324) in women, for a total over
the period 2000–2029 of 11 274 (90% CI 9157 to 14 411)
MM cases, 7247 (90% CI 5998 to 9156) in men, 4027 (90%
CI 3159 to 5255) in women. Observed and predicted numbers
of occupational and non-occupational cases by gender follow a
time pattern similar to total cases of MM (see online supple-
mentary ﬁgure S5).
DISCUSSION
In this study, we have documented a large impact of past use of
asbestos in the Lombardy Region, with over 4400 cases of MM in
both genders in a 13-year period (2000–2012), representing about
one-fourth of all cases of MM occurring in Italy. Occupational
exposure was more frequent in men (about 75%), than in women
(<40%). Incidence of MM is still increasing in Lombardy, with
the peak expected around 2019. We forecast there will be almost
7000 cases of MM in the period 2013–2029, for a total of more
than 11 000 cases of MM in 2000–2029.
The study was made possible by the high-quality population
registry of MM patients (RML).10 The performance of the
RML was recently evaluated via comparison of its data with that
of cancer registries covering four Lombardy provinces (Brescia,
Mantova, Milan, Sondrio) in 2000–2004: no case of MM was
missed by the RML. Identiﬁcation of sources of exposure to
Figure 2 Incidence rates (per 100 000 person-years) of malignant mesothelioma by age at diagnosis (20–99 years) (no cases were recorded in
persons <20 years of age. Owing to small number of cases, ages 20–24, 25–29, and 30–34 and birth cohorts 1900–1904, 1905–1909, 1970–1974,
1975–1979, 1980–1984, and 1985–1989 were combined) for different birth cohorts, Lombardy Region Mesothelioma Registry, 2000–2012.
Figure 3 Observed (2000–2012), model predicted and projected
(2013–2029, based on Poisson age-cohort models) numbers of
malignant mesothelioma cases per year, by gender, Lombardy Region
Mesothelioma Registry.
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asbestos was made possible in a large percentage of cases,
thanks to high rates of interview.
The Lombardy Region is the most populated (currently 10
million people), and has been the region with the largest
number of men employed in many industrial sectors in which
asbestos has been widely used, including mechanic (motor
vehicle construction and repair), metallurgy (iron and steel
foundries), chemical and rubber. In Lombardy, there were also
asbestos-cement factories. The second largest Italian asbestos-
cement factory was located in Broni, Pavia Province, Southeast
of Lombardy.12 For these reasons, a high burden of cases of
MM in men was largely expected. The high number of cases of
MM among women is partly explained by the presence of asbes-
tos in the textile and clothing production industries.
Investigations in this industrial sector had been prompted when
the registry started noting a very large number of cases of MM
among women. Industrial hygiene surveys showed that large
amounts of asbestos had been regularly used on the ceilings and
also on the walls of factories, in order to avoid condensation of
steam and reﬂection of noise. In addition, asbestos had also
been widely used to insulate water and steam pipes. The braking
systems of most machines also had asbestos gaskets, and on
several looms some brakes operated continuously.13 Asbestos
ﬁbres have been found in necropsy lung samples of textile
workers with MM.14
However, for a large proportion (39.2%) of women, we were
not able to identify any source of exposure to asbestos at inter-
view. Failure to identify occupational exposure to asbestos does
not necessarily imply that occupation did not play a role.
Rather, it may indicate that interview is an incomplete tool to
uncover exposure to asbestos (eg, many persons might not be
aware of the presence of asbestos at their workplace). Another
possible explanation for the high number of cases in women is
the widespread low-level environmental exposure to asbestos
from industries using asbestos, and from asbestos-containing
materials, most importantly asbestos-cement roofs in buildings.
A recent study found detectable levels of asbestos ﬁbres (mainly
amphiboles) in necroscopic lung samples taken from the general
population of Milan.15 However, effects of environmental
exposure to asbestos are even more difﬁcult to study16 and can
be usually evaluated only in areas with heavy environmental
contamination.17 For example, using RML data, we were able to
document a high impact of exposure to environmental asbestos
on occurrence of MM in women living near the asbestos-
cement factory in Broni.12
In Italy, until recently, only individuals with MM with recog-
nised occupational exposure to asbestos were entitled to ﬁle
claims for compensation. However, it has been estimated that
only about 50% of them were compensated in 1994–2006,
although an increasing trend in the more recent years has been
noted. The risk of not seeking and obtaining compensation is
higher for women, the elderly and in Central and South Italy.18
Cases of MM non-occupationally exposed, were not compen-
sated until 2014, when a law was passed to compensate affected
persons with para-occupational or environmental exposure and
ﬁrst diagnosis between 2015 and 2017.17
Our ﬁndings in women (high incidence of MM and low pro-
portion of occupationally exposed) are in line with results
regarding Italy as a whole: in the period 1993–2012, among
21 463 cases of MM, ReNaM recorded 38.4% women
(male/female ratio 2.5).7 17 To investigate more in depth the
role of occupation in women, a case–control study is in progress
in ﬁve Italian regions, including Lombardy. Also, other countries
(eg, Denmark, France and Spain) recorded a relatively high
number of affected women,19–21 while still others (eg, UK and
USA) showed a higher male/female ratio,22 23 reﬂecting different
male–female patterns of past exposure to asbestos.
Projections of occurrence of MM (incidence or mortality)
have been made in many countries in Europe (Britain, France,
Germany, Italy, the Netherlands and Switzerland),3
Australia,24 25 New South Wales (Australia),26 Brazil,27 Canada
and Quebec,28 Denmark,19 France,20 29 30 Germany,31 Italy,32
Veneto (Italy),33 Japan,34 35 the Netherlands,36 Spain,21 37
UK,22 38 39 South East England (UK),40 and USA.23 41–43 In
several of those studies, projections regarded only men.
Deﬁnitions of mesothelioma differed between studies: some
considered pleural cancer, some mesotheliomas of pleura plus
other sites, relying on different versions of the International
Classiﬁcation of Disease (usually the Ninth and Tenth
Revisions). The statistical model most often used to make pro-
jections was the Poisson age-cohort, either
classical3 19 23 28 29 31 32 34 36 38 40–42 or Bayesian.33 37 Others
used log-linear or generalised additive models relating incidence
of MM or mortality to past consumption of asbes-
tos.20 21 22 24 26 27 32 35 39 44 Some authors found quite differ-
ent predictions between the two approaches (eg, in France and
UK), showing that the Poisson age-cohort model may overesti-
mate future burden of MM compared with that obtained taking
into account past use of asbestos.20 22 Other authors, using
more recent data than those previously used to make projections
in six European countries,3 also pointed out the overestimation
of Poisson age-cohort models.45 However, still others (eg, in
New South Wales (Australia) and Italy) found a substantial
agreement between the two approaches.26 32
In this study, we used Poisson age-cohort models for two
main reasons; its relative simplicity and, most importantly, the
lack of information on past use of asbestos in the Lombardy
Region. In Italy, predictions of male pleural cancer mortality
were similar using different age-cohort, age-period-cohort and
models based on national asbestos production, import and
export patterns.32 All approaches indicated a peak of MM cases
between 2012 and 2024. Our results, which indicates a
maximum of MM occurrence in 2019 (417 cases) for men (267
cases) and women (150 cases), are consistent with those predic-
tions. Conversely, in other Italian regions, the peak may have
already occurred.33
CONCLUSIONS
MM registries are important for documentation of the impact
of use of asbestos on incidence of MM. Thanks to the existence
of the Lombardy Mesothelioma Registry, in this study, we
showed the continuing increase of MM in the region, reﬂecting
extensive occupational (mainly in men) and non-occupational
(mainly in women) exposure to asbestos in the past. More than
4000 cases were recorded in the ﬁrst 13 years of activity of the
registry (2000–2012), and almost 7000 are expected to occur in
the following years (2013–2029), for a total of more than
11 000 cases of MM in 30 years. Contrarily to other countries
in which the number of men diagnosed with MM was largely
predominant, in Lombardy (as in the rest of Italy), the number
of affected women is quite large. We hope these results help to
increase awareness of dangers of asbestos exposure in countries
that still use it but where its health effects are still overlooked.
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